Learning online can be a very different experience to what you may be traditionally accustomed to. Let’s go over some platform features and tips to help you get the most out of it.
You will be guided through each course by internationally renowned academic experts in their fields.
Each topic consists of text, visuals, audio, video and rich-media. You need to mark each topic as complete as you progress.
Courses consist of a series of modules and inside of each are topics. These break down subjects into manageable chunks.
Each module culminates with a short assessment to help you make sure you have understood the learning outcomes.
Those are the basics of the platform. You’ll get to know it more as you work through the content. We would love to hear your thoughts on the courses and platform, so please leave any feedback here.
“It was a real pleasure to be involved in building the modules on SGLT-2 inhibitors. This area is of huge interest to diabetes professionals and, coupled to “Diabetologia’s” special edition on this new class of drug, it is timely that EASD is launching three modules on SGLT-2 inhibitors at their annual conference”
“In a fast-moving field like diabetes, it is essential that a trusted name like EASD can work with professionals to build modules on demand. It’s brilliant that there is now a resource for people wanting to learn in their own time, to improve their skills and keep up to date with cutting-edge research with world-renowned experts”
“For many people working in the diabetes field, diabetes and Ramadan can be a particularly challenging issue. Working with the EASD team to build four modules on this topic was great. We have built them from a basic introduction to the topic through to complex drug regimen management changes during the fasting period”
This course gives you an overview of diabetic foot disease, while exploring in detail some of the common characteristics and difficulties this important but sometimes neglected complication of diabetes can give rise to.
This course has been created to introduce you to the diagnosis, consequences and treatment of diabetic kidney (diabetic nephropathy).
This course has been developed to introduce you to the mechanisms by which the autoimmune destruction of beta cells in the pancreatic islets of Langerhans occur which lead to the development of type 1 diabetes.
This course has been created to introduce you to the treatment and management of women with pre-existing diabetes before, during and after their pregnancy.
In this course, insulin pumps and continuous glucose monitoring are discussed using real life examples to help you understand how this technology works optimally. The third module considers the development of and clinical trials involving the closed loop.
This course has been created to introduce you to time in range, a new concept in glycaemic management that challenges the role of HbA1c.
This course introduces you to the current unmet need in type 1 diabetes and explores trial data in the use of adjunct therapies including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.
This course has been created to introduce you to the epidemiology and current screening controversies of GDM. Treatment, management and the long-term follow-up of women with GDM are also covered.
This course is designed to help you learn how to treat people with type 1 diabetes or type 2 diabetes before, during and after Ramadan.
The last day of this year’s American Diabetes Association (ADA) conference in San Francisco is only a half day – but it is quite a half day! The results from three clinical trials are reporting. Normally on the last day of any conference, attendance has shrunk dramatically. But not today and I enter into a […]
The penultimate day of the ADA conference starts with the Outstanding Scientific Achievement Award Lecture given, this year by Professor Sadaf Farooqi from the University of Cambridge. Entitled “Obesity and the Biology of Weight Regulation”, Professor Farooqi’s research focusses on severe obesity and people with this have the highest burden of complications. Deaths from diabetes […]
My third day in San Francisco starts with a session on “The Resilient Beta Cell in Type 2 Diabetes”. Emerging research is indicating that not all beta cells are equal and that some have very different levels of activity. Professor Jim Johnston from the University of British Columbia in Canada explains that individual beta bells […]
Develop your knowledge with cutting edge academic research
in an engaging interactive way
European Diabetology
